Regeneron Pharmaceuticals, Inc.【REGN】 業績・財務データ

市場

NASDAQ

Regeneron Pharmaceuticals, Inc.【REGN】 業績・財務データ

市場

NASDAQ

(単位:百万ドル) 2010/12/31 2011/12/31 2012/12/31 2013/12/31 2014/12/31 2015/12/31 2016/12/31 2017/12/31 2018/12/31 2019/12/31 2020/12/31 2021/12/31 2022/12/31
Product 4,834 5,568 12,117 6,894
Sanofi collaboration revenue 2,856
Other collaboration revenue 1,902 2,058
Other revenue 1,427 1,186 281 365
Revenue from contract with customer 7,863 8,497 16,072 12,173
Research and development 3,037 2,735 2,908 3,593
Acquired in-process research and development 255
Selling, general, and administrative 1,835 1,346 1,825 2,116
Product 362 492 1,773 800
Cost of collaboration and contract manufacturing 420 628 664 760
Other operating (income) expense, net 280 46 90
Total expenses 5,654 4,921 7,125 7,434
Income from operations 2,210 3,577 8,947 4,739
Other income (expense), net 250 291 436 179
Interest expense 30 57 57 59
Total other income (expense) 219 234 379 120
Income before income taxes 2,429 3,810 9,326 4,859
Income tax expense 313 297 1,251 520
Net income 2,116 3,513 8,075 4,338
Earnings Per Share, Basic 19.38 32.65 76.4 40.51
Earnings Per Share, Diluted 18.46 30.52 71.97 38.22
Weighted Average Number of Shares Outstanding, Basic 109 108 106 107
Weighted Average Number of Shares Outstanding, Diluted 115 115 112 114
Net income 2,116 3,513 8,075 4,338
Unrealized (loss) gain on debt securities 36 9 -56 -214
Unrealized gain (loss) on cash flow hedges -2 -1 1 1
Comprehensive income 2,149 3,521 8,020 4,126